会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 54. 发明申请
    • SCALABLE PRODUCTION OF STANDARDIZED EXTRACELLULAR VESICLES, EXTRACELLULAR VESICLE PREPARATIONS AND USES THEREOF
    • 标准制造的细胞外细菌,细胞外制剂及其用途的可生产
    • WO2016176500A1
    • 2016-11-03
    • PCT/US2016/029874
    • 2016-04-28
    • THE TEXAS A&M UNIVERSITY SYSTEM
    • PROCKOP, Darwin, J.KIM, Dong-kiNISHIDA, HidetakaSHETTY, Askok, K.
    • A61K35/28A61K35/12A61P29/00A61P25/28
    • A61K35/12A61K35/28C12N5/0663C12N2500/95
    • Preparations comprising an enriched population of extracellular vesicles (nEVs) having a negatively charged surface, and that are CD81+ and CD9-, are provided. Improved processes and methods for producing an enriched population of nEVs from non-murine cells, especially human origin cells and/or tissues, are disclosed. Therapeutic methods for using the preparations, including for reducing brain inflammation and treatment of various pathologies associated with brain inflammation, such as by intravenous or intranasal administration, are also described. Methods and preparations for reducing brain inflammation associated with traumatic brain injury (TBI) are also disclosed. A method for treating a patient having suffered a mild traumatic injury (mTMI), or concussion, such as a sports-related head injury, is also disclosed. The nEVs are also demonstrated to reduce the expression level of IL-Ιβ in brain tissue of an animal having had traumatic brain injury. Methods for improving cognitive function and performance in animals after a traumatic brain injury is also demonstrated using the preparations of nEVs disclosed herein.
    • 提供了包含具有带负电表面的富集的胞外囊泡(nEV)的制剂,并且是CD81 +和CD9-。 公开了用于从非鼠细胞,特别是人源细胞和/或组织产生富集的nEVs群体的改进的方法和方法。 还描述了使用制剂的治疗方法,包括用于减少脑炎症和治疗与脑炎症相关的各种病症,例如静脉内或鼻内给药。 还公开了减少与创伤性脑损伤(TBI)相关的脑炎症的方法和制剂。 还公开了治疗患有轻度创伤性损伤(mTMI)的患者或脑震荡等运动性头部损伤的方法。 还证明,nEVs可降低具有创伤性脑损伤的动物的脑组织中IL-1β的表达水平。 创伤性脑损伤后改善动物认知功能和表现的方法也使用本文公开的nEVs的制备来证明。